Long-Term Outcomes Following Multiply Recurrent Clostridioides Difficile Infection and Fecal Microbiota Transplantation

Fecal microbiota transplantation (FMT) is a commonly used therapy for multiply recurrent Clostridioides difficile (mrCDI). By altering the gut microbiota, there is the potential for FMT to impact the risk for cardiometabolic, intestinal or immune-mediated conditions. Likewise, the microbiota disturbance associated with mrCDI could potentially lead to these conditions. We aimed to assess the associations of mrCDI and FMT with cardiometabolic, immune-mediated diseases, and irritable bowel syndrome.

Source: Clinical Gastroenterology and Hepatology - December 8, 2020 Category: Gastroenterology Authors: Ghadeer Dawwas, Colleen M. Brensinger, Ravy K. Vajravelu, Qufei Wu, Colleen R. Kelly, Loren Laine, Gary D. Wu, James D. Lewis Source Type: research